Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Russia signs up for $34m Global Fund grant on HIV/AIDS:

This article was originally published in Clinica

Executive Summary

Russia and the Global Fund to Fight AIDS, Malaria and Tuberculosis have signed a funding agreement worth $34.2m over a first two-year phase of an HIV/AIDS programme. The grant will seek a 10-fold increase in the approximately 1,500 patients being treated across the seven regions worst affected by the condition. In the second year, it will be extended to 14 regions, with the aim of treating 75,000 patients. It is the second such grant in as many years. The Global Fund has so far disbursed $22.3m of a $31.6m grant signed in October 2003.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055523

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel